Pain Relief Drug Shortage Sparks Patient Concern

A significant shortage of a potent pain relief medication is creating concern among patients and healthcare providers. The supply of capsules and soluble tablets, used for severe pain unmanageable by common painkillers, is insufficient to meet the current demand. This scarcity means that pharmacies might have to resort to providing alternative medications to those affected.

Olivier Picard, Chair of the National Pharmacy Association, described the situation as 'distressing' and assured that pharmacies are managing existing supplies diligently to ensure patients receive necessary medication. NHS Grampian suggests that reducing dosages could be beneficial for some, as long-term co-codamol use is not recommended due to risks of tolerance, side effects, and dependence.

Co-codamol combines paracetamol with codeine. While the lowest strength (8/500) is available over-the-counter, higher strengths (15/500 and 30/500) require a doctor's prescription. Excessive consumption of co-codamol can be dangerous, particularly due to the paracetamol's potential to cause liver damage, emphasizing the importance of purchasing it only from registered pharmacies.